PHAT Competitors & Alternatives
Compare Phathom Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
PHAT
Main Stock$10.86
Tradestie Score
54
Market Cap
$871.90M
Revenue Growth
1.0%
Analyst Upside
+118.2%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.45
|
$879.90M | 5.4 | 61 | Compare |
|
DNA
Ginkgo Bioworks Holdings, Inc.
|
$8.86
|
$868.46M | - | 56 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$6.86
|
$867.49M | - | 55 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$16.46
|
$864.42M | - | 55 | Compare |
|
CRMD
CorMedix Inc.
|
$8.60
|
$862.55M | 4.1 | 61 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$36.57
|
$847.12M | - | 58 | Compare |
|
XNCR
Xencor, Inc.
|
$14.08
|
$843.75M | - | 61 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$23.61
|
$841.74M | - | 53 | Compare |
|
EVMN
EVMN
|
$24.25
|
$836.71M | - | 65 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$37.05
|
$832.47M | - | 55 | Compare |
More PHAT Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry